LogicBio Therapeutics Competitors, Revenue, Alternatives and Pricing
Estimated Revenue & Financials
- LogicBio Therapeutics's estimated annual revenue is currently $4M per year.
- LogicBio Therapeutics received $50.0M in venture funding in June 2017.
- LogicBio Therapeutics's estimated revenue per employee is $66,066
- LogicBio Therapeutics's total funding is $49M.
- LogicBio Therapeutics has 61 Employees.
- LogicBio Therapeutics grew their employee count by 15% last year.
- LogicBio Therapeutics currently has 3 job openings.
What Is LogicBio Therapeutics?
We are a genome editing company developing genetic medicines for the fight against rare pediatric diseases. GeneRide is a promoterless and nuclease-free approach to gene insertion which may improve the safety profile of AAV based gene therapies With GeneRide, the therapeutic gene is site-specifically integrated into the genome allowing durable gene expression in dividing cells and mature tissues. Furthermore, therapeutic gene expression is regulated by the targeted locus so production can be limited to specific cell types.keywords:N/A